| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dad5a6969d9c5113e87638a276760926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4e6ed934488193522f3f52b5c496f84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bafda23a1af2428128af168f6ae8c49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa5aa4c36e8a97c58040fd3fd0994c2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e40d73555b988e4cb5b6af42895d8aab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf4d06134f2ef31cb87df8cb4e9cd428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3696b0a5c800add4fbf4460737ed94a1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e379bf558bf53c5ae978cef10353f1ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_399568615ace72f0079d7d3d66f88dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ef91263e1377bc460d270d5dbfede74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b849a4466dc4a0564690d84f811f437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4091e6c0b2972d034ac33e77d1a17f08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45776c6b034a6dfe488e7270e4907a6e |
| publicationDate |
2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9726669-B2 |
| titleOfInvention |
Biomarkers for determining sensitivity of breast cancer cells to HER2-targeted therapy |
| abstract |
The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments. |
| priorityDate |
2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |